| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Future Medicinal Chemistry (Q2) | ||
| Dergi ISSN | 1756-8919 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 07-2025 |
| Cilt / Sayı / Sayfa | 17 / 13 / 1559–1573 | DOI | 10.1080/17568919.2025.2533003 |
| Makale Linki | https://doi.org/10.1080/17568919.2025.2533003 | ||
| UAK Araştırma Alanları |
Organik Kimya
|
||
| Özet |
| AimsThe quinolone scaffold is a crucial member of the heterocyclic compound family in modern medicinal chemistry, exhibiting a broad range of biological activities. Since 4-quinolones are known to interact with significant drug targets, and due to the remarkable pharmacological properties of 1,2,3-triazole compounds, a molecular hybridization approach was used to design novel 7-methoxyquinolone-substituted triazole hybrid conjugates (QN1-QN11).Materials and methodsThese hybrid compounds were evaluated to determine their anticancer activities in various breast and colon cancer cell lines, including BT20, MDA-MB-231, MCF7, and HT29. In addition, the apoptotic-like morphological changes in aggressive MDA-MB-231 cells were observed following treatment with the compounds for 48 hours. In silico studies, including molecular docking, molecular dynamics (MD) simulation, and MM/GBSA calculations … |
| Anahtar Kelimeler |
| anticancer | click chemistry | MD simulation | molecular docking | Quinolone |
| Atıf Sayıları | |
| Scopus | 3 |
| Google Scholar | 3 |
| Dergi Adı | Future Medicinal Chemistry |
| Yayıncı | Taylor and Francis Ltd. |
| Açık Erişim | Hayır |
| ISSN | 1756-8919 |
| E-ISSN | 1756-8927 |
| CiteScore | 4,8 |
| SJR | 0,501 |
| SNIP | 0,575 |